A pharmaceutical nonprofit was granted priority review from the FDA to make an inexpensive overdose-reversal drug for use without a prescription
A pharmaceutical nonprofit was granted priority review from the Food and Drug Administration to make an inexpensiveHarm Reduction Therapeutics Inc.
said its 3 milligram nasal spray naloxone formulation, called Rivive, had three times higher concentration in the blood of 36 participants than naloxone delivered as a shot. The company said Monday that the FDA gave it a target approval date of April 28. The FDA declined to comment.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Missouri woman tracks down, kills alleged carjackers at gas stationDemesha Coleman approached the vehicle with a male accomplice, who remains unidentified, and started shooting at three men whom she alleged with stealing her car.
Les mer »
Animal Tracks: Pets in need of homesThere are lots of dogs and cats at the Dothan Animal Shelter in need of good homes.
Les mer »
Missouri woman tracks down stolen Hyundai, kills 2 in shootout at gas stationA Missouri woman whose car was allegedly stolen is accused of tracking down the suspected thief on Wednesday, killing two men and wounding another, authorities said.
Les mer »
FDA changes Plan B label, says emergency contraceptive won't cause abortionThe new labels are intended to further distinguish emergency contraception — also known as the morning after pill — from abortion pills.
Les mer »
FDA changes Plan B packaging to clarify that it is not an abortion pillThe FDA is changing the informational packaging of the emergency contraceptive pill, Plan B One-Step, to clarify that it is not an abortion pill.
Les mer »